Imagen de Portada
Código QR

Recent Advances in the Treatment and Management of NASH.

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States (U.S.) and is soon to be the leading cause of liver transplantation. Patients at the greatest risk are those with obesity and type 2 diabetes. Weight loss and several pharmacological treatments can...

Descripción completa

Publicado en:Journal of Managed Care Medicine Vol. 24; no. 2; pp. 37 - 42
Autor principal: Lomonaco, M. Romina
Formato: tables/charts Journal Article
Publicado: National Association of Managed Care Physicians, Inc. 2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=151792609&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 151792609
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10941525
        9084
      jtl: Journal of Managed Care Medicine
      issn: 10941525
      maglogo: N
    pubinfo:
      dt: 2021
      vid: 24
      iid: 2
      pid: 54351
      pub: National Association of Managed Care Physicians, Inc.
      place: Glen Allen, Virginia
    artinfo:
      ui:
        151792609
        151792609
        151792609
        151792609
      ppf: 37
      ppct: 5
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Recent Advances in the Treatment and Management of NASH.
      aug:
        au: Lomonaco, M. Romina
        affil: Assistant Professor in Endocrinology, Diabetes and Metabolism at the University of Florida in Gainesville, FL
      sug:
        subj:
          Nonalcoholic Fatty Liver Disease Drug Therapy
          Nonalcoholic Fatty Liver Disease Etiology
          Disease Management
          Diabetes Mellitus, Type 2 Complications
          Obesity Complications
          Nonalcoholic Fatty Liver Disease Diagnosis
          Biopsy Methods
          Weight Loss
          Patient Education
          Disease Progression
          Life Style Changes
      ab: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States (U.S.) and is soon to be the leading cause of liver transplantation. Patients at the greatest risk are those with obesity and type 2 diabetes. Weight loss and several pharmacological treatments can often be successful to reverse steatohepatitis and prevent disease progression.
      pubtype: Academic Journal
      doctype:
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N